Glitaray M Forte 0.5mg/1000mg Tablet
By Glitaray M
Rx
15 Tablet in a Strip

Composition
Glimepiride(0.5mg) + Metformin(1000mg)

Manufacturer - Lloyd Healthcare Pvt Ltd
702, Balaji Business Park, Andheri Kurla Road, Marol Naka, Andheri East, Gamdevi, Marol, Andheri East, Mumbai, Maharashtra 400059

Expires on or after
October, 2025

liver
When using Glitaray M Forte 0.5mg/1000mg Tablet, it is important to be cautious if you have liver disease. You may need a dose adjustment, so it is best to consult your doctor before taking this medication. Typically, Glitaray M Forte 0.5mg/1000mg Tablet is initiated at a low dose for individuals with mild to moderate liver disease. However, it is not advised for use in patients with severe liver disease. Remember to seek guidance from your doctor when considering this medication for liver-related issues.

kidney
Caution Glitaray M Forte 0.5mg/1000mg Tablet requires caution in kidney disease. Dose adjustment may be necessary, but not recommended in severe kidney disease. Regular kidney function tests are advised during use. Consult your doctor before using.

alcohol
It is not safe to drink alcohol while taking Glitaray M Forte 0.5mg/1000mg Tablet.

driving
When taking Glitaray M Forte 0.5mg/1000mg Tablet, be cautious while driving. Low or high blood sugar levels can affect your ability to drive safely. Avoid driving if you experience these symptoms.

pregnancy
Glitaray M Forte 0.5mg/1000mg Tablet may be unsafe during pregnancy, as animal studies suggest it may harm the developing baby. Your doctor will evaluate the risks and benefits before prescribing. Please consult your doctor before use.

breastfeeding
Caution is advised when considering breastfeeding while using Glitaray M Forte 0.5mg/1000mg Tablet as it is deemed unsafe and may pose a risk of toxicity to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
₹130
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 01-Oct-2024